Actinium Pharmaceuticals, Inc.(NYSE Amex Equities : ATNM)
ATNM After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
Health Technology » Biotechnology
|SNSS||Sunesis Pharmaceuticals, Inc.||-0.46%||8.65||0.7%||$604.67m|
|GILD||Gilead Sciences, Inc.||-0.70%||71.19||1.0%||$455.28m|
|REGN||Regeneron Pharmaceuticals, Inc.||-1.18%||638.90||2.7%||$418.56m|
|VRTX||Vertex Pharmaceuticals, Inc.||-0.80%||183.61||1.9%||$245.25m|
|ISEE||IVERIC bio, Inc.||0.86%||16.37||0.0%||$193.25m|
|DVAX||Dynavax Technologies Corp.||1.17%||19.83||5.7%||$156.65m|
|LIFE||aTyr Pharma, Inc.||-17.87%||10.25||2.1%||$156.36m|
Actinium Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. It engages in the development of novel targeted therapies known as Antibody Radiation-Conjugates (ARCs), which combine the targeting ability of antibodies with the cell killing ability of radiation. The company was founded in 2002 and is headquartered in New York, NY.